腰椎硬膜外皮质类固醇注射减轻全膝关节置换术后前六周的亚急性疼痛并改善膝关节功能:一项双盲随机试验
该双盲随机试验纳入108例接受全膝关节置换术的膝骨关节炎患者,随机在拔除硬膜外导管前接受40 mg曲安奈德加1%利多卡因或单用1%利多卡因。皮质类固醇加利多卡因组在术后第3天至第7周的运动痛更低,术后6周WOMAC评分更优;静息痛和关节活动度在3个月内无差异。
要点
- 皮质类固醇加利多卡因组术后第3天至第7周的运动痛VAS低于单用利多卡因组(p<0.05)。
- 术后6周皮质类固醇加利多卡因组WOMAC平均总分28分,单用利多卡因组33分(95%CI,-8.6至-0.6分;p=0.03)。
- 两组静息痛和3个月内膝关节活动度无差异(p>0.05)。
核心结论
- 与单用利多卡因相比,腰椎硬膜外皮质类固醇注射减轻运动痛达7周,并改善术后6周膝关节功能。
- 3个月随访期间,两组静息痛和膝关节活动度未检测到差异。
- 硬膜外皮质类固醇可能改善全膝关节置换术后早期恢复阶段的患者满意度。
研究设计与样本
- 双盲随机临床试验,纳入108例因膝骨关节炎接受全膝关节置换术并通过硬膜外导管接受镇痛药物48小时的患者。
- 患者随机在拔除导管前接受40 mg(1 mL)曲安奈德加5 mL 1%利多卡因,或单用6 mL 1%利多卡因。
- 采用多水平回归模型估计组间差异,结局记录至术后3个月。
- 证据等级:治疗性I级。
主要发现
- 皮质类固醇加利多卡因组术后第3天至第7周的运动痛VAS平均水平低于单用利多卡因组(p<0.05)。
- 第7周时平均差异为-7分(95%CI,-12.8至-1.0分;p=0.033)。
- 术后6周皮质类固醇加利多卡因组WOMAC平均总分28分,单用利多卡因组33分(95%CI,-8.6至-0.6分;p=0.03)。
- 3个月期间两组静息痛水平无差异(p>0.05)。
- 3个月期间两组膝关节活动度无差异(p>0.05)。
临床怎么用
- 作者结论认为,腰椎硬膜外皮质类固醇注射可减轻全膝关节置换术后运动痛达7周并改善术后6周膝关节功能。
- 作者结论认为,硬膜外皮质类固醇可能改善全膝关节置换术后早期恢复阶段的患者满意度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pain control immediately following total knee arthroplasty (TKA) has been a focus for orthopaedists. However, control of subacute pain, which may persist up to 3 months, is usually not optimized. The efficacy of epidural corticosteroids in reducing pain after surgery is documented, but data on their efficacy in controlling subacute pain after TKA are lacking. Our aim was to investigate the efficacy of an epidural corticosteroid in controlling pain in the first 3 months following TKA using a double-blinded randomized clinical trial. METHODS: One hundred and eight patients with osteoarthritis of the knee who underwent TKA and received analgesic drugs through an epidural catheter for 48 hours were randomized to receive either 40 mg (1 mL) of triamcinolone acetonide plus 5 mL of 1% lidocaine, or 6 mL of 1% lidocaine alone before catheter removal. The outcomes of interest were pain level during motion and at rest, knee function, and range of motion, which were recorded up to 3 months after surgery. Multilevel regression models were used to estimate the differences between groups. RESULTS: The corticosteroid + lidocaine group had a lower average level of pain during motion compared with the lidocaine-only group, as measured by a visual analog scale (VAS), from day 3 to 7 weeks postoperatively (p < 0.05). At 7 weeks, the mean difference was -7 points (95% confidence interval [CI], -12.8 to -1.0 points; p = 0.033). The corticosteroid + lidocaine group also had a better mean overall modified Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score at 6 weeks postoperatively (28 compared with 33 points; 95% CI, -8.6 to -0.6 points; p = 0.03). There was no difference between the groups in the level of pain at rest and knee range of motion during the 3-month period (p > 0.05). CONCLUSIONS: Lumbar epidural corticosteroid injection reduced pain during motion for 7 weeks and provided better knee function at 6 weeks postoperatively compared with lidocaine alone. There was no difference detected with respect to pain at rest and knee range of motion during the 3-month follow-up. Epidural corticosteroids could improve patient satisfaction during the early weeks of recovery after TKA. LEVEL OF EVIDENCE: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
引用
- Tammachote N, Seangleulur A, Kanitnate S, et al. Lumbar Epidural Corticosteroid Injection Reduces Subacute Pain and Improves Knee Function in the First Six Weeks After Total Knee Arthroplasty: A Double-Blinded Randomized Trial. J Bone Joint Surg Am. 2018. PMID: 29870446. doi:10.2106/JBJS.17.00578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。